GH - CIK 0001576280
Guardant Health, Inc. (GH) reported net income of -$416.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$416.30M | +4.6% |
| FY 2024 | -$436.40M | +9.0% |
| FY 2023 | -$479.40M | +26.8% |
| FY 2022 | -$654.60M | -70.1% |
| FY 2021 | -$384.80M | -408.7% |
| FY 2019 | -$75.65M | +11.1% |
| FY 2018 | -$85.06M | -2.2% |
| FY 2017 | -$83.22M | -80.4% |
| FY 2016 |
Guardant Health, Inc. (GH) reported net income of -$416.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Guardant Health, Inc.'s net income declined from -$46.14M to -$416.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$46.14M |
| - |